No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
HUMA Humacyte
- 7.710
- +0.220+2.94%
Close May 29 16:00 ET
- 7.820
- +0.110+1.43%
Post 19:53 ET
918.14MMarket Cap-7710P/E (TTM)
7.880High7.395Low1.93MVolume7.420Open7.490Pre Close14.82MTurnover2.36%Turnover RatioLossP/E (Static)119.08MShares7.88052wk High35.05P/B628.63MFloat Cap1.96052wk Low--Dividend TTM81.53MShs Float17.450Historical High--Div YieldTTM6.48%Amplitude1.960Historical Low7.691Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Benchmark Co. Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $15
Benchmark Co. analyst Bruce Jackson maintains $Humacyte(HUMA.US)$ with a buy rating, and maintains the target price at $15.According to TipRanks data, the analyst has a success rate of 29.9% and a tot
Humacyte (HUMA) Receives a Buy From Benchmark Co.
URBN, SHLS and VSAT Are Among After Hour Movers
Humacyte(HUMA.US) Director Buys US$50,030.25 in Common Stock
$Humacyte(HUMA.US)$ Director Wallace Max N. purchased 8,005 shares of common stock on May 20, 2024 at an average price of $6.25 for a total value of $50,030.25.Source: Announcement What is statement o
This Humacyte Insider Increased Their Holding By 91% Last Year
CRSP, NYMT and SBRA Are Among After Hour Movers
Comments
$Humacyte(HUMA.US$ look at The insider buying it doesn't stop it's 2 to 3 times a week huge insider buying there's something seriously big that's going to be happening to this company.. forget the fact that the stocks doubled they're still buying at these prices here at six and a half $7 that means they're looking for much higher prices in the future
2
4
$HUMA - Benchmark Reiterates Buy on Humacyte, Maintains $15 Price Target.
One company that has been drawing significant attention from investors and analysts alike is Humacyte (HUMA). This pioneering firm, known for its innovative approaches in regenerative medicine, has once again found itself in the spotlight following a reaffirmation of confidence from the esteemed financial services firm, Benchmark Co. $Humacyte(HUMA.US$
https://stockregion.app/p/medical-company-receives-buy-rating
One company that has been drawing significant attention from investors and analysts alike is Humacyte (HUMA). This pioneering firm, known for its innovative approaches in regenerative medicine, has once again found itself in the spotlight following a reaffirmation of confidence from the esteemed financial services firm, Benchmark Co. $Humacyte(HUMA.US$
https://stockregion.app/p/medical-company-receives-buy-rating
$Humacyte(HUMA.US$ Senator Tommy Tuberville filed 8 security purchases, including small biotech company Humacyte (HUMA) which has been testing to repair injuries in Ukraine.
2
2
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
bobokiller : 你有購買？
10baggerbammOP bobokiller: I own at 6.70 15,000 shares.
SeaBird0110 : Yea, I’m up 93% since last month on this
10baggerbammOP SeaBird0110: you are smarter than me I saw where the congressman bought stock in the company and I posted the link but I see this all the time I get a subscription that shows every move that every Congress person does for buys and sells so I can't do everything but obviously this one there's something cooking something really really big cooking inside of it